$132 Million is the total value of HARBERT FUND ADVISORS, INC.'s 18 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ENZ | ENZO BIOCHEM INC | $14,164,000 | +19.4% | 5,620,681 | 0.0% | 10.73% | -26.0% | |
QUMU | QUMU CORP | $10,927,000 | +73.3% | 1,367,522 | 0.0% | 8.28% | +7.5% | |
STRM | STREAMLINE HEALTH SOLUTIONS | $5,213,000 | 0.0% | 3,341,637 | 0.0% | 3.95% | -38.0% | |
LNDC | LANDEC CORP | $3,245,000 | +11.6% | 299,116 | 0.0% | 2.46% | -30.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
I3 VERTICALS INC | 23 | Q2 2024 | 43.3% |
ENZO BIOCHEM INC | 23 | Q2 2024 | 30.1% |
STREAMLINE HEALTH SOLUTIONS | 23 | Q2 2024 | 6.4% |
TRANSACT TECHNOLOGIES INC | 21 | Q2 2024 | 5.3% |
QUMU CORP | 17 | Q4 2022 | 8.3% |
IDENTIV INC | 16 | Q2 2024 | 7.7% |
TURTLE BEACH CORP | 14 | Q2 2024 | 9.1% |
VSE CORP | 13 | Q3 2023 | 5.2% |
ACCURAY INC | 13 | Q2 2024 | 4.1% |
FENNEC PHARMACEUTICALS INC | 13 | Q2 2024 | 3.6% |
View HARBERT FUND ADVISORS, INC.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Global Indemnity Group, LLC | October 28, 2022 | 324,764 | 3.0% |
View HARBERT FUND ADVISORS, INC.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR/A | 2024-01-26 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
View HARBERT FUND ADVISORS, INC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.